Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ispaghula husk
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ispaghula husk 3.5g efferv gran sach gluten free sugar free
0106010E0AAADAD
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | 108,047 |
|
Fybogel Orange 3.5g effervescent granules sachets SF
0106010E0BBABAD
|
Fybogel | Ispaghula husk | Gastro-Intestinal System | 72,130 |
|
Fybogel 3.5g effervescent granules sachets plain SF
0106010E0BBAAAD
|
Fybogel | Ispaghula husk | Gastro-Intestinal System | 16,736 |
|
Fybogel Lemon 3.5g effervescent granules sachets SF
0106010E0BBACAD
|
Fybogel | Ispaghula husk | Gastro-Intestinal System | 12,705 |
|
Fybogel Hi-Fibre Orange 3.5g effervescent granules sachets
0106010E0BKAAAD
|
Senokot (Ispahulag husk) | Ispaghula husk | Gastro-Intestinal System | 10,261 |
|
Ispaghula husk 3.5g gran for susp sachets gluten free
0106010E0AAATAT
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | 2,864 |
|
Fybogel Hi-Fibre Lemon 3.5g effervescent granules sachets
0106010E0BKABAD
|
Senokot (Ispahulag husk) | Ispaghula husk | Gastro-Intestinal System | 2,717 |
|
Ispaghula husk 3.5g gran for susp sach GF SF
0106010E0AAAUAU
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | 627 |
|
Ispagel Orange 3.5g effervescent granules sachets
0106010E0BJAAAD
|
Ispagel Orange | Ispaghula husk | Gastro-Intestinal System | 499 |
|
Solgar Psyllium husks fibre 500mg capsules
0106010E0BNAAAW
|
Solgar Psyllium | Ispaghula husk | Gastro-Intestinal System | 36 |
|
YourFIBRE High-Fibre 3.5g gran for susp sachets
0106010E0BPAAAU
|
YourFIBRE | Ispaghula husk | Gastro-Intestinal System | 23 |
|
Fibrelief Orange 3.5g granules sachets
0106010E0BLAAAT
|
Fibrelief | Ispaghula husk | Gastro-Intestinal System | 4 |
|
Fibrelief 3.5g granules sachets
0106010E0BLABAU
|
Fibrelief | Ispaghula husk | Gastro-Intestinal System | 3 |
|
Ispaghula husk 3.5g/dose efferv gran gluten free sugar free
0212000J0AAAAAA
|
Ispaghula husk (Lipid Lowering) | Ispaghula husk | Cardiovascular System | 3 |
|
AAA Ispaghula husk 3.5g efferv gran sach GF SF
0106010E0BQAAAD
|
AAA (Ispaghula husk) | Ispaghula husk | Gastro-Intestinal System | 1 |
|
AAA Ispaghula husk 3.5g/dose efferv gran GF SF
0212000J0BDAAAA
|
AAA (Ispaghula husk granules) | Ispaghula husk | Cardiovascular System | No data available |
|
AaceGel 3.5g effervescent granules sachets
0106010E0BRABAD
|
AaceGel | Ispaghula husk | Gastro-Intestinal System | No data available |
|
AaceGel 500mg capsules
0106010E0BRAAAW
|
AaceGel | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Fybogel Orange 3.5g effervescent granules
0212000J0BCAAAA
|
Fybogel (Lipid Lowering) | Ispaghula husk | Cardiovascular System | No data available |
|
Fybogel Orange 3.5g effervescent granules sachets SF
0106010E0BBABAH
|
Fybogel | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Fybozest Orange 3.5g effervescent granules
0212000J0BBAAAA
|
Fybozest | Ispaghula husk | Cardiovascular System | No data available |
|
Generic Solgar Psyllium husks fibre 500mg capsules
0106010E0AAAWAW
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Husk oral powder
0106010E0BMAAAV
|
Husk | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Isogel 90% granules
0106010E0BCAAAC
|
Isogel | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Ispaghula husk 3.4g oral pdr sachets gluten free sugar free
0106010E0AAAJAJ
|
Ispaghula husk (Laxative) | Ispaghula husk | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.